Related Experiment Video
Updated: Jul 10, 2026
10:39
Single Cell Measurements of Vacuolar Rupture Caused by Intracellular Pathogens
Published on: June 12, 2013
Quantitation of B. Pseudomallei in clinical samples
Vanaporn Wuthiekanun1, Direk Limmathurotsakul, Gumphol Wongsuvan
1Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
The American Journal of Tropical Medicine and Hygiene
|November 7, 2007
Summary
This study quantifies Burkholderia pseudomallei in melioidosis patients. Bacterial counts varied significantly across blood, urine, respiratory secretions, and pus samples, informing future clinical research.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Research
Background:
- Melioidosis, a serious infection caused by Burkholderia pseudomallei, requires accurate quantification of bacterial load for effective treatment and research.
- Understanding pathogen distribution in clinical samples is crucial for developing diagnostic and therapeutic strategies.
Purpose of the Study:
- To prospectively quantify Burkholderia pseudomallei (B. pseudomallei) in various clinical specimens from patients diagnosed with melioidosis.
- To assess the feasibility of using clinical samples for advanced molecular studies, such as expression microarray analysis.
Main Methods:
- A prospective study involving 414 patients with confirmed melioidosis.
- Quantification of B. pseudomallei colony-forming units per milliliter (CFU/mL) in blood, urine, respiratory secretions, and pus samples.
Main Results:
- Median bacterial counts varied significantly across sample types: blood (1.1 CFU/mL), urine (1.5 x 10^4 CFU/mL), respiratory secretions (1.1 x 10^5 CFU/mL), and pus (1.1 x 10^7 CFU/mL).
- These quantitative data highlight the substantial bacterial burden in different clinical sites.
Conclusions:
- The quantitative data provide critical insights into bacterial load in melioidosis patients.
- Findings support the potential for utilizing clinical specimens in future molecular research, including expression microarray analysis, to better understand disease pathogenesis.
